Skip to main content

SureSwab® Advanced Candida Vaginitis (CV), TMA

Test code: 10121

This is an in vitro nucleic acid amplification test for the detection of RNA from microorganisms associated with vulvovaginal candidiasis. The assay utilizes transcription-mediated amplification (TMA) to detect and qualitatively report results for the following organisms: Candida species group (C albicans, C tropicalis, C parapsilosis, C dubliniensis) and Candida glabrata.1

Unlike the SureSwab, Candidiasis, PCR test, the SureSwab Advanced Candida Vaginitis (CV), TMA test will not report the individual Candida species detected (C albicans, C tropicalis, C parapsilosis, C dubliniensis). In addition, SureSwab Advanced Candida Vaginitis (CV), TMA uses a Food and Drug Administration (FDA)-cleared test, whereas the SureSwab, Candidiasis, PCR is a laboratory-developed test.

This assay also allows for the self-collection of vaginal specimens by patients in a clinical setting.


  1. Aptima® CV/TV Assay. Package insert. Hologic Inc; 2021.


This FAQ is provided for informational purposes only and is not intended as medical advice. Test selection and interpretation, diagnosis, and patient management decisions should be based on the clinician’s education, clinical expertise, and assessment of the patient.


Document FAQS.268 Version: 0

Version 0: Effective 08/30/2022 to present